**Core Concept**
Lidocaine is a local anesthetic and antiarrhythmic medication that can cause toxicity when its clearance is impaired, leading to elevated plasma concentrations. In patients with circulatory failure, the liver's ability to metabolize lidocaine is compromised, increasing the risk of toxicity.

**Why the Correct Answer is Right**
The liver enzyme cytochrome P450 3A4 (CYP3A4) is primarily responsible for lidocaine's metabolism. In patients with circulatory failure, the decreased perfusion of the liver impairs CYP3A4 activity, leading to decreased lidocaine metabolism and increased plasma concentrations. This can result in cardiac or central nervous system toxicity.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant to the scenario described.
* **Option B:** While lidocaine can cause toxicity at high doses, the scenario described involves standard doses and impaired clearance due to circulatory failure, not high doses.
* **Option D:** This option is not a recognized mechanism of lidocaine toxicity.

**Clinical Pearl / High-Yield Fact**
In patients with circulatory failure, consider reducing the dose of lidocaine or using an alternative antiarrhythmic medication to minimize the risk of toxicity.

**Correct Answer: B. Increased volume of distribution.**

✓ Correct Answer: A. Lidocaine concentration are initially higher in relatively well perfused tissues such as brain and heart